Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SECOND-QUARTER HIGHLIGHTS: TOTAL REVENUE OF $683.5M, UP 62.7%NET INCOME OF $41.9M, UP 111.9%; GAAP EPS OF $0.66, UP 69.2%;ADJUSTED EBITDA OF $117.2M, UP 127.9%; ADJUSTED DILUTED EPS OF $0.95, UP...
-
On track for 30% operating profit margin by 2027 in line with our Pivot to Growth Strategy.Q2 2025 shows 10th consecutive quarter of year-over-year (YoY) revenue growth; Revenues of $4.2 billion, +1%...
-
SEATTLE, July 29, 2025 (GLOBE NEWSWIRE) -- Sound Financial Bancorp, Inc. (the "Company") (Nasdaq: SFBC), the holding company for Sound Community Bank (the "Bank"), today reported net income of $2.1...
-
JACKSONVILLE, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers,” “Regency” or the “Company”) (Nasdaq: REG) today reported financial and operating results for the...
-
HOUSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”, “Orion”), a leading specialty construction company, today reported its financial results for the...
-
2025 Second Quarter Revenue of $514.5 Million, up 14.7% year-over-year Q2 Diluted EPS (GAAP) of $0.40, up 43.9% from $0.28 in Q2 of 2024 Q2 Adjusted Diluted EPS (Non-GAAP) (1) of $0.49, up 20.3%...
-
Press releaseParis, 29 July 2025 Financial results at 30 June 2025 Solid first-half results Robust retail commercial performance in France, Europe and Africa & Middle East3.8% growth in...
-
Huntsville, AL, July 28, 2025 (GLOBE NEWSWIRE) -- Applied Research Associates, Inc. (ARA) will highlight next-generation defense solutions at the 2025 Space and Missile Defense Symposium August 5-7...
-
WASHINGTON, D.C., July 25, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and...
-
Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to...